Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06917664
PHASE4

Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

Sponsor: China National Center for Cardiovascular Diseases

View on ClinicalTrials.gov

Summary

This study aims to evaluate the effect of angiotensin receptor/neprilysin inhibitors (ARNI) on improving ischemic mitral regurgitation (IMR) in patients with coronary artery disease undergoing isolated coronary artery bypass grafting (CABG) through a randomized controlled clincial trial.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

220

Start Date

2025-06-05

Completion Date

2027-06

Last Updated

2025-08-27

Healthy Volunteers

No

Interventions

DRUG

sacubitril/valsartan

Sacubitril/valsartan therapy after isolated CABG

Locations (1)

China National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, China